Trial Profile
Temozolomide Plus Bevacizumab Chemotherapy in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status (KPS<70)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms ATAG
- 15 Jun 2011 New trial record